US OptionsDetailed Quotes
SYK241220C270000
- 118.35
- 0.000.00%
15min DelayClose Nov 29 13:00 ET
0.00High0.00Low
118.35Open118.35Pre Close0 Volume2 Open Interest270.00Strike Price0.00Turnover91.25%IV-0.97%PremiumDec 20, 2024Expiry Date122.15Intrinsic Value100Multiplier19DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9720Delta0.0008Gamma3.17Leverage Ratio-0.1649Theta0.1335Rho3.08Eff Leverage0.0574Vega
Stryker Corp Stock Discussion
Sign in to post a comment
The Federal Reserve on Wednesday implemented its first rate cut in over four years, reducing the benchmark rate by 50 basis points to a range of 4.75%-5%.
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...
+7
75
9
The stock price of $Intuitive Surgical (ISRG.US)$ , the maker of Da Vinci surgical robot system surged 9.34% after its earnings report on Friday, and its market value exceeded $160 billion.
Second quarter revenue of $2.01 billion increased by 14% compared with $1.76 billion in the second quarter of 2023. The second quarter GAAP net income attributable to Intuitive was $52...
Second quarter revenue of $2.01 billion increased by 14% compared with $1.76 billion in the second quarter of 2023. The second quarter GAAP net income attributable to Intuitive was $52...
+1
24
1
The recent insider sale of Stryker shares at the current price is viewed negatively. However, high insider ownership is seen positively, suggesting management's consideration for shareholders. Yet, the absence of insider buying over the past year is worrisome.
The EPS decline doesn't align with share price changes, indicating other factors. Management might be prioritizing revenue growth over EPS. The company's recent performance improvement suggests potential business momentum.
$Stryker Corp (SYK.US)$ shares advanced 6.6% after the company gave a better-than-expected outlook for 2024 and delivered an earnings beat, prompting analysts to upgrade the stock.
The company sees 2024 adjusted earnings to reach $11.70 to $12 a share, according to its press release. That's higher than the $11.54 estimate of analysts polled by Capital IQ, according to MT Newswires.
"Based on our momentum for 2023, strong proce...
The company sees 2024 adjusted earnings to reach $11.70 to $12 a share, according to its press release. That's higher than the $11.54 estimate of analysts polled by Capital IQ, according to MT Newswires.
"Based on our momentum for 2023, strong proce...
3
Investors feel Stryker's high P/E ratio is justified due to its favorable earnings outlook. Their optimism on consistent earnings growth maintains the elevated ratio as expectations for a drop in earnings are low. A significant change in conditions could alter this supportive investor sentiment.
No comment yet
steven smith38 : hummmmmm. have to do fracture on this one almost tap out.